BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $385,894 | -3.5% | 9,857 | +0.1% | 0.09% | +4.4% |
| Q2 2023 | $400,094 | -2.8% | 9,845 | +0.1% | 0.09% | -9.1% |
| Q1 2023 | $411,620 | +2.4% | 9,833 | +6.6% | 0.10% | 0.0% |
| Q4 2022 | $401,908 | +12.3% | 9,222 | +0.1% | 0.10% | +6.5% |
| Q3 2022 | $358,000 | -0.6% | 9,212 | +8.4% | 0.09% | +40.9% |
| Q2 2022 | $360,000 | -7.0% | 8,501 | +0.1% | 0.07% | 0.0% |
| Q1 2022 | $387,000 | -3.2% | 8,494 | +1.2% | 0.07% | -8.3% |
| Q3 2021 | $400,000 | -1.7% | 8,390 | 0.0% | 0.07% | -5.3% |
| Q2 2021 | $407,000 | +5.4% | 8,390 | +0.6% | 0.08% | -5.0% |
| Q1 2021 | $386,000 | -1.5% | 8,340 | +1.2% | 0.08% | -9.1% |
| Q4 2020 | $392,000 | +14.6% | 8,240 | +3.3% | 0.09% | 0.0% |
| Q3 2020 | $342,000 | +62.1% | 7,975 | +54.1% | 0.09% | +10.0% |
| Q2 2020 | $211,000 | +19.9% | 5,175 | +6.2% | 0.08% | +3.9% |
| Q1 2020 | $176,000 | – | 4,875 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE INVESTMENT CONSULTANTS HOLDING COMPANY, LLC | 18,736 | $675,000 | 0.94% |
| CORRADO ADVISORS, LLC | 9,565 | $344,000 | 0.32% |
| Rikoon Group, LLC | 19,188 | $692,000 | 0.29% |
| Eudaimonia Partners, LLC | 4,875 | $176,000 | 0.08% |
| Arete Wealth Advisors, LLC | 10,183 | $367,000 | 0.07% |
| CENTAURUS FINANCIAL, INC. | 8,465 | $305,000 | 0.06% |
| Cetera Advisors LLC | 17,379 | $627,000 | 0.03% |
| Jacobi Capital Management LLC | 4,034 | $145,000 | 0.03% |
| Financial Advantage, Inc. | 773 | $27,000 | 0.02% |
| MID ATLANTIC FINANCIAL MANAGEMENT INC/ADV | 5,868 | $212,000 | 0.02% |